StevenGDuboisMD

Clinical Trials

• Sunitinib in Treating Young Patients With Refractory Solid Tumors Start of enrollment: 2006 Oct 01

  Completed

  Phase 1

• N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk Neuroblastoma Start of enrollment: 2007 Jan 01

  Completed

  Phase 1

• Collecting and Storing Biological Samples From Patients With Ewing Sarcoma Start of enrollment: 2008 Feb 04

  Completed

• Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL Start of enrollment: 2010 Jun 01

  Terminated

  Phase 1, Phase 2

• N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed Neuroblastoma Start of enrollment: 2010 Mar 01

  Completed

  Phase 1

• Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22

  Active, not recruiting

  Phase 3

• High-Dose 131I-MIBG Therapy Combined With Vincristine and Five Days of Irinotecan for Resistant/Relapsed Neuroblastoma Start of enrollment: 2011 Mar 01

  Completed

  Phase 1

• A Study Of Panobinostat In Children With Refractory Hematologic Malignancies Start of enrollment: 2011 Mar 01

  Completed

  Phase 1

• A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL Start of enrollment: 2011 Dec 01

  Terminated

  Phase 1, Phase 2

• Study of MLN8237 in Combination With Irinotecan and Temozolomide Start of enrollment: 2012 May 01

  Completed

  Phase 1, Phase 2

• Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid Tumors Start of enrollment: 2012 Aug 01

  Completed

  Phase 1

• Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors Start of enrollment: 2012 Nov 14

  Completed

  Phase 1

• MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma Start of enrollment: 2013 Nov 01

  Completed

  Phase 1

• 131I-MIBG Alone VS. 131I-MIBG With Vincristine and Irinotecan VS131I-MIBG With Vorinostat Start of enrollment: 2014 Jul 01

  Completed

  Phase 2

• Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors Start of enrollment: 2014 Mar 28

  Completed

  Phase 1, Phase 2

• Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies Start of enrollment: 2014 May 16

  Completed

  Phase 1, Phase 2

• Alternating Systemic Chemotherapy and Intra-Arterial Melphalan (IAM) Chemotherapy in Children With Intra-Ocular Retinoblastoma Start of enrollment: 2014 Jul 23

  Terminated

  Phase 1

• VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors Start of enrollment: 2014 Sep 01

  Completed

  Phase 1

• A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children Start of enrollment: 2015 Dec 16

  Active, not recruiting

  Phase 1, Phase 2

• PAZIT Study for Children and Young Adults With Relapsed or Refractory Sarcoma Start of enrollment: 2017 Jun 06

  Completed

  Phase 1

• Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer Start of enrollment: 2018 Nov 01

  Completed

  Phase 1

• Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer Start of enrollment: 2019 Sep 27

  Active, not recruiting

  Phase 1

• Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma Start of enrollment: 2013 Jul 01

  Active, not recruiting

  Phase 1

  Roles: Contact

• Join now to see all